New Millennium Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
New Millennium Group's PFE Position: Q4 2025 in Review
New Millennium Group increased its Pfizer (PFE) stake by 148% in Q4 2025, buying an estimated $98.5K and bringing the position to 6,544 shares worth $163K. The position accounts for 0.07% of the portfolio, ranked #74.
New Millennium Group first reported a position in PFE in Q2 2022 and has held it in 14 quarters since. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- New Millennium Group held 6,544 shares of Pfizer worth $163K as of Q4 2025.
- New Millennium Group bought 3,907 Pfizer shares in Q4 2025, an estimated $98.5K.
- Pfizer made up 0.07% of New Millennium Group's portfolio in Q4 2025, its #74 holding.
- New Millennium Group first reported a position in Pfizer in Q2 2022 and has held it in 14 quarters since.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.